Showing results (1651-1660 of 2,402) with videos related to

Sort By:
Pageof 241
The Journal of Dermatological Treatment|September 11, 2023
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Evangeline Pierce, Meghan Feely, et al.
Frontiers in Neuroinformatics|December 18, 2010
Reproducibility of graph metrics in FMRI networksQawi K Telesford, Ashley R Morgan, Satoru Hayasaka, et al.
Journal of the Mechanical Behavior of Biomedical Materials|July 13, 2015
A comparative study of the effects of different bioactive fillers in PLGA matrix composites and their suitability as bone substitute materials: A thermo-mechanical and in vitro investigationR L Simpson, S N Nazhat, J J Blaker, et al.
Allergy|January 11, 2018
Epidemiology of atopic dermatitis in adults: Results from an international surveyS Barbarot, S Auziere, A Gadkari, et al.
Infection and Immunity|March 21, 2007
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal routeEaswaran Ravichandran, Fetweh H Al-Saleem, Denise M Ancharski, et al.
New Microbes and New Infections|July 13, 2018
Genomic analyses reveal two distinct lineages of <i>Corynebacterium ulcerans</i> strainsR Subedi, V Kolodkina, I C Sutcliffe, et al.
Dermatology and Therapy|July 28, 2025
Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16Amy S Paller, Andrew Blauvelt, Weily Soong, et al.
Water Research|June 6, 2022
RT-qPCR and ATOPlex sequencing for the sensitive detection of SARS-CoV-2 RNA for wastewater surveillanceWarish Ahmed, Aaron Bivins, Suzanne Metcalfe, et al.
Advances in Therapy|January 7, 2024
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b StudyEmma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Chest|February 3, 2016
Reduced Antiviral Interferon Production in Poorly Controlled Asthma Is Associated With Neutrophilic Inflammation and High-Dose Inhaled CorticosteroidsJodie L Simpson, Melanie Carroll, Ian A Yang, et al.
Pageof 241